Structure of comorbid psychopathological disorders in patients with type 2nd diabetes mellitus
DOI:
https://doi.org/10.14739/2310-1210.2017.2.95730Keywords:
type 2nd diabetes mellitus, psychopathology, diagnosisAbstract
Aim: to identify and explore the structure of comorbid psychopathological disorders in patients with type 2nd diabetes mellitus (DM).
Materials and methods: 543 patients with type 2nd DM were included into the study. The average age of patients was (56.2 ± 0.65) years. The patients were divided into three groups according to the severity of DM. The first clinical group (CG-1) included 57 patients with type 2nd DM of mild severity, who was treated in outpatient department; the average age in the group was (51.8 ± 1.28) years. The second clinical group (CG-2) made up of 312 patients with type 2nd DM, moderate severity, they were in inpatient department; the median age of the group was (55.1 ± 1.12) years. The third clinical group (CG-3) included 174 patients with type 2nd DM, severe degrees of severity, they undergone inpatient treatment too; average age in the group was (61.8 ± 0.85) years.
Research methods: clinical-anamnesis, clinical- psychopathological, statistical.
Research results. The study established the incidence of non-psychotic mental disorders of varying severity in patients with type 2nd DM at the level of 94.11 %, among them, for 91.16 % – of psychogenic origin.
Proportional correlation between the severity of type 2nd DM and the absence of comorbid psychopathological manifestations was detected (rs = -0.3416, p < 0.01). It is revealed that the dominant psychopathological syndromes among all patients with type 2nd DM were psychoorganic (62.43 %), dyssomnia (60.86 %), asthenic (55.58 %) and anxiety (43.05 %) syndromes. Structure of the dominant psychopathological syndromes was established depending on severity of type 2nd DM: in CG-1 dominated dyssomnia (36.84 %), anxiety (31.58 %), psychoorganic (21.05 %) syndromes; in CG-2 – psychoorganic (65.38 %), asthenic (40.38 %), dyssomnia (38.46 %), anxiety (37, and 82 %) syndromes; in CG-3 – dyssomnia (97.70 %), asthenic (89.08 %), organic mental (70.69 %), anxious 48.28 %) syndromes. Significant prevalence among all study groups was detected for hysterical (χ2 = 13.416, p < 0.01) and phobic syndromes (χ2 = 6.161, p < 0.05) in g CG-1 compared to CG-2 and CG-3; and asthenia (χ2 = 162.663, p < 0.01), anxiety (χ2 = 7.177, p < 0.05), depression (χ2 = 13.298, p < 0.01), dyssomnia (χ2 = 171.058, p < 0.01), hypochondric (χ2 = 19.331, p < 0.01), psychoorganic (χ2 = 47.830, p < 0.01) syndromes in CG-3 compared to CG-1 and CG-2. Direct correlation between the severity of type 2nd DM and the presence of the clinical picture asthenic (rs = 0.4033, p < 0.01) and psychoorganic (rs = 0.2344, p < 0.01) syndromes was identified; and inverse correlation between the severity of type 2nd DM and the presence of the clinical manifestation of patients with hysterical syndrome (rs = -0.1444, p < 0.01).
Conclusion. The study established the frequency of occurrence and genesis of nonpsychotic mental disorders of varying severity in patients with type 2 DM. Correlation between the severity of type 2nd DM and comorbid psychopathological symptoms was revealed. The identified dominant psychopathological syndromes among patients with type 2nd DM, as well as the structure of psychopathological disorders depended on the severity of type 2nd DM.
References
International Expert, Committee (2009). International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care, 32(7), 1327–1334. doi: 10.2337/dc09-9033.
Khosravan, S., Alami, A., & Rahni, S. G. (2015). Effects of Continuous Care Model Based Non-Pharmacological Intervention on Sleep Quality in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial. Int. J. Community Based Nurs. Midwifery, 3(2), 96–104.
Roy, T., & Lloyd, C. E. (2012) Epidemiology of depression and diabetes: a systematic review. Journal of affective disorders, 142, 8–21. doi: 10.1016/S0165-0327(12)70004-6.
Smyth, S., & Heron, A. (2006). Diabetes and obesity: the twin epidemics. Nature Medicine, 12(1), 75–80. doi: 10.1038/nm0106-75.
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5), 1047–1053. doi: 10.2337/diacare.27.5.1047.
Knutson, K. L., Ryden, A. M., Mander, B. A., & Van Cauter, E. (2006) Role of Sleep Duration and Quality in the Risk and Severity of Type 2 Diabetes. Mellitus Arch. Inten Med., 166, 1768–1774. doi: 10.1001/archinte.166.16.1768.
Fatati, G. (2014) Diabetes, psychosocial distress and quality of care. Recenti Prog. Med., 105(10), 374–378. doi: 10.1701/1626.17668.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
